Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: Role of corticotropin releasing factor

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 457-464

  Nazzaro, Cristiano ^a,b   Barbieri, Mario ^a   Varani, Katia ^a   Beani, Lorenzo ^a   Valentino, Rita J ^b   Siniscalchi, Anna ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

5 Hydroxytryptamine; Corticotropin releasing factor; Dorsal raphe nucleus; Electrophysiology; nociceptin orphanin FQ; Swim stress

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; ANTALARMIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLOHEXIMIDE; DIAZEPAM; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST;

4 AMINOBUTYRIC ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FORCED SWIMMING TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GAMMA-AMINOBUTYRIC ACID; MALE; NEURAL INHIBITION; NEURONS; OPIOID PEPTIDES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, OPIOID; SEROTONIN; STRESS, PSYCHOLOGICAL; SWIMMING; TIME FACTORS;

EID: 72049116554     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.09.004     Document Type: Article

References (56)

1. Bale T.L., and Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 525-557
2. Bambico F.R., Katz N., Debonnel G., and Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27 43 (2007) 11700-11711
3. Bianchi C., Marani L., Barbieri M., Marino S., Beani L., and Siniscalchi A. Effects of nociceptin/orphanin FQ and endomorphin-1 on glutamate and GABA release, intracellular [Ca2+] and cell excitability in primary cultures of rat cortical neurons. Neuropharmacology 47 6 (2004) 873-883
4. Calò G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129 7 (2000) 1261-1283
5. 2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br. J. Pharmacol. 136 2 (2002) 303-311
6. Calò G., Guerrini R., Salvadori S., Burmeister M., Kapusta D.R., Lambert D.G., and Regoli D. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. CNS Drugs Rev. 11 2 (2005) 97-112
7. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 21 24 (2001) 9917-9929
8. Ciccocioppo R., Martin-Fardon R., Weiss F., and Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport 12 6 (2001) 1145-1149
9. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., and Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J. Neurosci. 23 28 (2003) 9445-9451
10. Civelli O. The orphanin FQ/nociceptin (OFQ/N) system. Results Probl. Cell Differ. 46 (2008) 1-25
11. Davis S., Heal D.J., and Stanford S.C. Long-lasting effects of an acute stress on the neurochemistry and function of 5-hydroxytryptaminergic neurones in the mouse brain. Psychopharmacol. (Berl.) 118 3 (1995) 267-272
12. Devine D.P., Hoversten M.T., Ueda Y., and Akil H. Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress. J. Neuroendocrinol. 15 1 (2003) 69-74
13. Gavioli E.C., and Calò G. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn Schmiedebergs Arch. Pharmacol. 372 5 (2006) 319-330
14. Grammatopoulos D.K., Randeva H.S., Levine M.A., Kanellopoulou K.A., and Hillhouse E.W. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J. Neurochem. 76 2 (2001) 509-519
15. Guerrini R., Calo G., Rizzi A., Bianchi C., Lazarus L.H., Salvadori S., Temussi P.A., and Regoli D. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J. Med. Chem. 40 12 (1997) 1789-1793
16. Hammack S.E., Pepin J.L., DesMarteau J.S., Watkins L.R., and Maier S.F. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav. Brain Res. 147 1-2 (2003) 55-64
17. Hammack S.E., Schmid M.J., LoPresti M.L., Der-Avakian A., Pellymounter M.A., Foster A.C., Watkins L.R., and Maier S.F. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J. Neurosci. 23 3 (2003) 1019-1025
18. Heinrichs S.C., De Souza E.B., Schulteis G., Lapsansky J.L., and Grigoriadis D.E. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Neuropsychopharmacology 27 2 (2002) 194-202
19. Ikeda K., Kobayashi K., Kobayashi T., Ichikawa T., Kumanishi T., Kishida H., Yano R., and Manabe T. Functional coupling of the nociceptin/orphanin FQ receptor with the G-protein-activated K+ (GIRK) channel. Brain Res. Mol. Brain Res. 45 1 (1997) 117-126
20. Imaki T., Wang X.Q., Shibasaki T., Harada S., Chikada N., Takahashi C., Naruse M., and Demura H. Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Brain Res. Mol. Brain Res. 32 2 (1995) 261-270
21. Jankowski M.P., and Sesack S.R. Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons. J. Comp. Neurol. 468 4 (19 Jan 2004) 518-529
22. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma Jr. F.J., Nothacker H.P., and Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A. 94 26 (1997) 14854-14858
23. Kirby L.G., Freeman-Daniels E., Lemos J.C., Nunan J.D., Lamy C., Akanwa A., and Beck S.G. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J. Neurosci. 28 48 (2008) 12927-12937
24. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22 2 (2000) 148-162
25. Korosi A., Veening J.G., Kozicz T., Henckens M., Dederen J., Groenink L., van der Gugten J., Olivier B., and Roubos E.W. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Res. 1072 1 (2006) 46-54
26. Lambert D.G. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat. Rev. Drug Discov. 7 8 (2008) 694-710
27. Le Maître E., Vilpoux C., Costentin J., and Leroux-Nicollet I. Opioid receptor-like 1 (NOP) receptors in the rat dorsal raphe nucleus: evidence for localization on serotoninergic neurons and functional adaptation after 5,7-dihydroxytryptamine lesion. J. Neurosci. Res. 81 4 (2005) 488-496
28. Lukkes J.L., Forster G.L., Renner K.J., and Summers C.H. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. Eur. J. Pharmacol. 578 2-3 (2008) 185-193
29. Meis S., and Pape H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J. Physiol. 532 Pt 3 (2001) 701-712
30. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340 1 (1997) 1-15
31. Mikics E., Barsy B., Barsvári B., and Haller J. Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field. Horm. Behav. 48 2 (2005) 152-162
32. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 2 (2003) 83-244
33. Mlinar B., Tatini F., Ballini C., Nencioni S., Della Corte L., and Corradetti R. Differential autoinhibition of 5-hydroxytryptamine neurons by 5-hydroxytryptamine in the dorsal raphe nucleus. Neuroreport 16 12 (2005) 1351-1355
34. Moran T.D., Abdulla F.A., and Smith P.A. Cellular neurophysiological actions of nociceptin/orphanin FQ. Peptides 21 7 (2000) 969-976
35. Nazzaro C., Barbieri M., Valentino R.J., Siniscalchi A., 2008. Previous stress potentiates the inhibitory effects of nociceptin on dorsal raphe nucleus neurons: potential role of corticotropin-releasing factor, Society for Neuroscience Meeting, Washington, DC; Abstr. 282.3/OO10.
36. Nazzaro C., Marino S., Barbieri M., and Siniscalchi A. Inhibition of serotonin outflow by nociceptin/orphanin FQ in dorsal raphe nucleus slices from normal and stressed rats: role of corticotropin releasing factor. Neurochem. Int. 54 (2009) 378-384
37. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 4 (1999) 503-547
38. Orozco-Cabal L., Pollandt S., Liu J., Shinnick-Gallagher P., and Gallagher J.P. Regulation of synaptic transmission by CRF receptors. Rev. Neurosci. 17 3 (2006) 279-307
39. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press Inc., Oxford
40. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., and Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 24 6 (2004) 1305-1311
41. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., and Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18 6 (1998) 492-502
42. Price M.L., Kirby L.G., Valentino R.J., and Lucki I. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacol. (Berl.) 162 4 (2002) 406-414
43. Reinscheid R.K. The orphanin FQ/nociceptin receptor as a novel drug target in psychiatric disorders. CNS Neurol. Disord. Drug Targets 5 2 (2006) 219-224
44. Reyes B.A., Valentino R.J., and Van Bockstaele E.J. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 149 1 (2008) 122-130
45. Roche M., Commons K.G., Peoples A., and Valentino R.J. Circuitry underlying regulation of the serotonergic system by swim stress. J. Neurosci. 23 3 (2003) 970-977
46. Rodi D., Zucchini S., Simonato M., Cifani C., Massi M., and Polidori C. Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacol. (Berl.) 196 4 (2008) 523-531
47. 3H]-5-HT release from rat cerebral cortex slices. Br. J. Pharmacol. 128 1 (1999) 119-123
48. Skelton K.H., Nemeroff C.B., Knight D.L., and Owens M.J. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J. Neurosci. 20 3 (2000) 1240-1248
49. Swiergiel A.H., Li Y., Wei Z.Y., and Dunn A.J. Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats. Neurochem. Int. 52 6 (2008) 1220-1225
50. Tao R., Ma Z., Thakkar M.M., McCarley R.W., and Auerbach S.B. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux. Neuroscience 147 1 (2007) 106-116
51. Valentino R.J., and Commons K.G. Peptides that fine-tune the serotonin system. Neuropeptides 39 1 (2005) 1-8
52. Vandermaelen C.P., and Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 289 1-2 (1983) 109-119
53. Varani K., Calò G., Rizzi A., Merighi S., Toth G., Guerrini R., Salvadori S., Borea P.A., and Regoli D. Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships. Br. J. Pharmacol. 125 (1998) 1485-1490
54. Vaughan C.W., and Christie M.J. Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmacol. 117 8 (1996) 1609-1611
55. Waselus M., Valentino R.J., and Van Bockstaele E.J. Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor in the rat dorsal raphe serotonin system. J. Comp. Neurol. 482 (2005) 155-165
56. Waselus M., Valentino R.J., and Van Bockstaele E.J. Differential trafficking of corticotropin-releasing factor receptor type 1 and 2 following exposure to swim stress. Biol. Psychiatry 66 1 (2009) 76-83